Investors
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
05/09/17Visualant Granted Biological Tissue Patent
Disruptive Platform and IoT Sensor Technology Evaluates Biological Tissue SEATTLE--(BUSINESS WIRE)--May 9, 2017-- Visualant, Incorporated (OTCQB: VSUL) – an emerging leader in next-generation optical sensor technology – announced today that it has received its 11th U.S. patent. The invention relates to the use of the company’s disruptive ChromaID™ technology for identifying and analyzing biological tissue, and has many potential applications i... 
Printer Friendly Version
04/20/17Visualant Appoints Phillip Bosua to Scientific Advisory Board
SEATTLE--(BUSINESS WIRE)--Apr. 20, 2017-- Visualant, Inc. (OTCQB: VSUL) – a provider of chromatic-based identification, authentication and diagnostic solutions, with its patented ChromaID™ technology, announced today that it has appointed Phillip Bosua to its Scientific Advisory Board. Bosua is an internationally recognized inventor and innovator. His expertise in lighting led him to found LIFX (www.lifx.com) where he created the world’s f... 
Printer Friendly Version
03/08/17Visualant Announces Shareholder Update
SEATTLE--(BUSINESS WIRE)--Mar. 8, 2017-- Visualant, Inc. (OTCQB: VSUL) – a provider of chromatic-based identification, authentication and diagnostic solutions, with its ChromaID™ technology, released today a letter from its Founder and Chief Executive Officer providing an overview of the Company’s technology and an update on recent activities of the Company. Dear Shareholders, I am pleased to update you on Visualant and its recent ... 
Printer Friendly Version